Literature DB >> 14992013

[Progress in locked nucleic acid research].

Sheng-Mao Li1, Xiang Xu, Hua-Ping Liang, Lei Li.   

Abstract

Locked nucleic acid (LNA) is a novel oligonucleotide analogue in which 2'-O and 4'-C positions in the b-D-ribofuranosyl ring are joined via an O-methylene, S-methylene or amino-methylene moiety, locked in a C3'-endol3E north (N)-type furanose conformation. LNAs posses many properties, such as extraordinarily high hybridize affinities for complementary DNA/RNA sequences, remarkable antisense activity, nuclease resistance, good aqueous solubility and none detactable toxicity, et al. LNAs is a most promising molecule for development of diagnostics and therapeutics. For example, apply LNAs to single--nucleotide polymorphisms genotyping, telomerase activity have been efficiently suppressed by LNA oligomers, efficient cleavage of highly structured RNA has been achieved using LNA-modified DNAzymes (LNAzymes), and so on.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14992013

Source DB:  PubMed          Journal:  Sheng Li Ke Xue Jin Zhan        ISSN: 0559-7765


  1 in total

1.  Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.

Authors:  Y Zhang; Z Qu; S Kim; V Shi; B Liao; P Kraft; R Bandaru; Y Wu; L M Greenberger; I D Horak
Journal:  Gene Ther       Date:  2010-12-23       Impact factor: 5.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.